{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:28:58Z","timestamp":1758814138572},"reference-count":7,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2014,3,25]],"date-time":"2014-03-25T00:00:00Z","timestamp":1395705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,4,1]]},"abstract":"<jats:p>This paper reports the case of a platinum-sensitive patient who developed moderately differentiated squamous cell carcinoma of the oral cavity after exposure to pegylated liposomal doxorubicin (PLD). The authors conclude that identification of patients at major risk of PLD-related secondary malignancies and strategies for early detection and reduction of oral carcinogenesis are priorities for future study.<\/jats:p>","DOI":"10.1634\/theoncologist.2013-0421","type":"journal-article","created":{"date-parts":[[2014,3,26]],"date-time":"2014-03-26T02:51:25Z","timestamp":1395802285000},"page":"429-429","source":"Crossref","is-referenced-by-count":6,"title":["Squamous Cell Carcinoma of the Oral Cavity in a Woman With a 9-Year History of Ovarian Cancer: Is Exposure to Pegylated Liposomal Doxorubicin a Factor?"],"prefix":"10.1093","volume":"19","author":[{"given":"Giovanni","family":"Randon","sequence":"first","affiliation":[{"name":"II Medical Oncology, Istituto Oncologico Veneto, Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Ornella","family":"Nicoletto","sequence":"additional","affiliation":[{"name":"II Medical Oncology, Istituto Oncologico Veneto, Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Milite","sequence":"additional","affiliation":[{"name":"II Medical Oncology, Istituto Oncologico Veneto, Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Muggia","sequence":"additional","affiliation":[{"name":"New York University Cancer Institute, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierfranco","family":"Conte","sequence":"additional","affiliation":[{"name":"II Medical Oncology, Istituto Oncologico Veneto, Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,3,25]]},"reference":[{"key":"2021122308524356900_B1","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1634\/theoncologist.2011-0216","article-title":"Squamous cell carcinoma of the oral cavity in nonsmoking women: A new and unusual complication of chemotherapy for recurrent ovarian cancer?","volume":"17","author":"Cannon","year":"2012","journal-title":"The Oncologist"},{"key":"2021122308524356900_B2","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s10147-012-0400-1","article-title":"Does long-term treatment with Doxil\u00ae predispose patients to oral cancer?","volume":"18","author":"Ben-David","year":"2013","journal-title":"Int J Clin Oncol"},{"key":"2021122308524356900_B3","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1634\/theoncologist.2012-0429","article-title":"Aggressive squamous cell carcinoma of the oral tongue in a woman with metastatic giant cell tumor treated with pegylated liposomal doxorubicin","volume":"17","author":"Gu","year":"2012","journal-title":"The Oncologist"},{"key":"2021122308524356900_B4","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1634\/theoncologist.2011-0280","article-title":"Squamous cell carcinoma of the oral tongue in two patients previously exposed to long-term pegylated liposomal doxorubicin","volume":"17","author":"Bonomi","year":"2012","journal-title":"The Oncologist"},{"key":"2021122308524356900_B5","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1634\/theoncologist.2012-0358","article-title":"Long-term pegylated liposomal doxorubicin use and oromaxillary squamous cell carcinoma in endometrial cancer","volume":"17","author":"Matsuo","year":"2012","journal-title":"The Oncologist"},{"key":"2021122308524356900_B6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1634\/theoncologist.2013-0021","article-title":"Squamous cell carcinomas of the tongue and oral cavity as secondary malignancies: what factors are implicated?","volume":"18","author":"Muggia","year":"2013","journal-title":"The Oncologist"},{"key":"2021122308524356900_B7","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1200\/JCO.2008.19.1684","article-title":"Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: A phase III trial of the Gynecological Cancer InterGroup","volume":"27","author":"Bookman","year":"2009","journal-title":"J Clin Oncol"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pericles-gcp.literatumonline.com\/doi\/pdf\/10.1634\/theoncologist.2013-0421","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/pericles-gcp.literatumonline.com\/doi\/full-xml\/10.1634\/theoncologist.2013-0421","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/19\/4\/429\/41862302\/oncolo_19_4_429.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/19\/4\/429\/41862302\/oncolo_19_4_429.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T08:53:36Z","timestamp":1640249616000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/19\/4\/429\/6399548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,25]]},"references-count":7,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,3,25]]},"published-print":{"date-parts":[[2014,4,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.2013-0421","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,4,1]]},"published":{"date-parts":[[2014,3,25]]}}}